Abridge vs Freed
This is less a rivalry than a fork in the road, because each product serves a buyer the other does not. Abridge is enterprise only: Best in KLAS for Ambient AI in 2025 and 2026, the category's largest peer reviewed study with 1,306 Kaiser Permanente clinicians in NEJM AI, and native Epic embedding with bidirectional sync; there is no self serve path and no individual plan. Freed is the opposite motion: published pricing from $39 a month, a Business Associate Agreement by default, sign up and generate notes the same day, and more than 32 million visits transcribed, at the cost of a browser extension push with no native EHR write back and a documented specialty ceiling outside primary care. If your failure mode is structured data and auditability across a health system, start with Abridge. If your failure mode is procurement itself, a solo or small practice that needs working notes this week, start with Freed.
- Evidence a committee will accept: the largest independent peer reviewed study in the category, 1,306 clinicians at Kaiser Permanente in NEJM AI, corroborated by Best in KLAS for Ambient AI in both 2025 and 2026; Freed has no peer reviewed outcome study on record with this index.
- Structured data must land in the chart: native embedding across Epic Haiku, Canto, and Hyperdrive with bidirectional note sync, extending into structured orders and real time prior authorization, where Freed's EHR Push is a browser extension with no discrete field write back.
- Oversight is auditable: Linked Evidence maps every part of a generated note back to the source audio so any sentence can be verified against what was said before signing.
- You can see the whole cost before talking to anyone: $39 Starter for up to 40 notes, $79 Core unlimited, $119 Premier adding EHR Push and coding, with a seven day trial and no credit card; Abridge publishes no price and offers no individual plan.
- Compliance comes standard at the entry tier: a HIPAA Business Associate Agreement by default on all tiers, SOC 2 Type II, automatic deletion of recordings, and an opt out from model training, so the $39 plan is a viable production configuration for a US clinician.
- Zero deployment is the feature: sign up and generate notes the same day with no sales call or IT project; community health center Camarena Health deployed 55 clinicians across 24 sites without formal implementation.
Side-by-Side
| Axis | A Abridge |
F Freed |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | — | |
| Model and Technology Transparency | — | — |
| Clinical and Operational Evidence | — | |
| AI Safety and PHI Stewardship | — | |
| HIPAA and BAA Posture | — | |
| Security Certifications and Trust Center | — | — |
| FDA and Regulatory Status | — | — |
| AI Governance and Bias Disclosure | — | — |
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | — | — |
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Volume and deployment figures for both vendors are vendor published, including Abridge's 250 plus health systems and Freed's 32 million transcribed visits. Abridge's evidence grade reflects the scale and venue of the Kaiser Permanente study, not a re verification of its findings. Freed's tradeoffs are stated plainly by vendor and third party review alike: EHR Push works through a Chrome extension into browser based EHRs with no native API write back, and specialty depth outside primary care is a known weakness with procedure heavy documentation needing more editing. Freed's pricing is fully published; Abridge is enterprise only, with a third party estimate near $2,500 per clinician per year recorded as an estimate.